In 2016, Mali recorded 5900 new HIV infections and 6100 AIDS-related deaths. In 2016, 110 000 people were living with HIV, 35% of whom had access to antiretroviral treatment. Among pregnant women living with HIV, 35% had access to treatment or prophylaxis to prevent HIV transmission to their children [5] .
Increased access to antiretroviral treatment has significantly increased patient survival and comfort. However, for treatment to be more effective, it is imperative to have good immunological and virological monitoring of patients.
Biological monitoring is therefore essential for the effective management of people living with HIV. The initial assessment of patients and the follow-up of treated and untreated patients is based on the measurement of certain biochemical parameters (transaminases, amylases), haematological parameters (CBC), the measurement of circulating CD4 T lymphocytes and the viral load expressing RNA copy number in blood or breast milk 2.
MATERIAL AND METHODS

Study Population
The study was carried out on 1018 samples of seropositive people from the Centre d'Ecoute, de Soin, d'Animation et de Conseils; the Centre National d'Appui à la Maladie; the Forces Armies Maladies; Point G Hospital and Gabriel Touré Hospital with more or less different biochemical parameters
Dosing of Biochemical Parameters
The tubes were immediately identified and centrifuged at 2000 rpm for 5 minutes. After centrifugation, the sera were taken from the pre-numbered cuvettes.
The KENZA TX 240 is switched on and the reagents for glucose, creatinine, cholesterol, triglycerides and transaminases were placed in the KENZA TX 240 in the indicated positions. Calibration and quality control of the reagents was done with the normal control sera and with the reagent multivibrator.
Patient names were recorded on the KENZA TX 240 by selecting the requested analysis and cell positions. The cells were placed in the selected positions.
RESULTS AND DISCUSSION
Distribution of Samples by Gender
At the end of the work, the samples were divided according to gender.
Figure 1 shows the distribution of the sample by gender
Figure1. Gender Distribution of the Sample
During our study period, the female sex was in the majority with 66.5%. The distribution of infected subjects shows a predominance of infected females with 66.50%. This is in agreement with several authors Déné who found 73.2% in 2010, who had worked on monitoring the biological parameters of people living with HIV on ARV treatment at EPH in Gao, Mali and Mamadou found 55.10% in 2004, who studied the lipid profile of PLWHIV according to immune status in Ouagadougou [7] . This could be explained by their greater vulnerability, socio-cultural constraints and their physiological make-up, which make them more susceptible to HIV infection. 
Distribution of Samples by Age Group
The age distribution of the sample is shown in Figure 2 .
Figure2. Age distribution of the sample
During our study period, the 1018 people living with HIV received were between the ages of 1 and 75. The age groups 30-44 and 45-59 were in the majority with 38.3% and 30.6% of patients respectively, which shows that children and adolescents are less contaminated. The age groups 30-44 years and 45-59 years were in the majority with 38.3% and 30.6% of patients respectively. This result is comparable with that of Kibangou in 2004 in Congo, where the 29-51 age group was also the majority age group [8] . These age groups correspond to the most sexually active segments of the population. Patients on ARV treatment were more represented with 60.10% than the inclusion patients, which may indicate a decrease in infection. Figure 4 shows the distribution of the sample as a function of blood glucose status.
Distribution of Samples According to Blood Glucose Status
Figure4. Sample distribution according to blood glucose status
Most blood glucose levels were in the normal range with 64.9% compared to 3.9% for hyperglycemia. At inclusion, hypoglycemia was 31.9% close to that of Déné who found that in 37.5% of cases normal blood glucose was 63.3% [9] . This can be explained by the fact that the patients came in advanced stages of the disease. Figure 5 shows the distribution of the sample by creatinine level.
Sample Distribution by Creatinine Level
Figure5. Sample Distribution by Creatinine Level
Biochemical Profile of People Living with HIV
The normal creatinine level is 67.5% with a low of 26.3% and a high of 6.2%. The normal creatinine level is higher than that of the patients in inclusion at 68.8% but with an increase in hyper creatinine with 10.7% of cases probably due to renal toxicity of ARVs, close to that found by Déné 7 .3% at M6 but much lower than the result of Dicko who found 24.6% of cases. Normal creatinine was 66.0% lower than Déné's 92.7%, and renal disease was observed in 8.4% of cases similar to Dicko's finding of 8% abnormal [9, 10] . Figure 6 shows the distribution of the sample by AST rate.
Distribution of Samples by AST Level
Figure6. Sample Distribution by AST Rate
The normal AST value is 77.2% compared to a high rate of 22.8%. Figure 7 shows the distribution of the sample by ALT levels.
Distribution of the Sample by ALT Level
Figure7. Sample Distribution by ALT Rate
Patients with normal ALT levels represent 89.3% compared to a minority of high ALT levels of 10.7%. The normal AST level was 79.5% and a normal ALT level of 89.6% while 20.5% and 10.4% respectively had elevated AST and ALT levels. This may be due to an advanced stage of the disease. Dicko had found 89.3% during the follow-up of patients under treatment in 2006 at the Infectious Diseases Department of the University Hospital Centre of Pont G and 92.7% for Dene of normal ALT levels. The normal values for ALT and AST were 89.0% and 75.8% respectively and the elevated AST was 24.2% and 11.0% for ALT higher than the inclusion patients, this decrease in normal transaminase levels is explained by the efficacy of the treatment. Dene had found 83.2% and Dicko 95.7% of cases with normal ALT levels [9, 10] . Figure 8 shows the distribution of the sample by cholesterol level.
Distribution of Samples by Cholesterol Levels.
Figure8. Sample distribution by cholesterol level
The normal value for cholesterol is 74.0% with 23.6% low and 2.4% high. Figure 9 shows the distribution of the sample by triglyceride level.
Figure9. Sample distribution by triglyceride level
Patients with a normal triglyceride value were 68.2% with 27.3% high and 4.4% low triglycerides. The normal triglyceride level was 71.7% and for cholesterol 65.1%, with low levels 4.3% for triglycerides and 4.7% for cholesterol which can be a sign of infectious pathology (severe tuberculosis) and high values 23.9% for triglyceridemia and 27.3% for cholesterol which is a sign of dyslipidemia and cardiovascular risks. Normal lipid levels are lower than those of the inclusion patients with 72.2% for cholesterol and 65.1% for triglycerides with elevated levels of 1.7% for cholesterol and 30.2% for triglycerides much higher than that of Dene who found 10.0% of cases this elevation is related to treatment [9] .
CONCLUSION
The study was based on the determination of the biochemical profile of people living with HIV under monitoring at the National Institute of Public Health Research. At the end of this study, we can say that the parameters analyzed are affected either by intelligence or by gender requiring follow-up.
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